Colgate-Palmolive officer proposes $2.01M share sale
The notice traces the proposed shares to restricted-stock-unit awards and reports two earlier sales by Noel Wallace in August 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Colgate-Palmolive Co. officer Noel Wallace reported a proposed sale of 20,000 common shares through Merrill Lynch, with an aggregate market value of $2,005,162.84 and an approximate sale date of November 5, 2026. The notice lists the shares as coming from restricted stock unit awards: 8,508 shares vested on October 2, 2024, and 11,492 shares vested on February 13, 2025. It also reports two prior sales by Noel Wallace: 161,021 shares on August 4, 2026, and 161,021 shares on August 5, 2026.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock unit awards financial
issuer equity compensation plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.